Synaptogenix News

Synaptogenix | 4: Statement of changes in beneficial ownership of securities-Director Singer William S.

Apr 10 16:13 ET

Synaptogenix | 4: Statement of changes in beneficial ownership of securities-Director Bernstein Bruce

Apr 10 16:10 ET

Synaptogenix | 4: Statement of changes in beneficial ownership of securities-Director SCHECHTER JONATHAN

Apr 10 16:09 ET

Synaptogenix | 4: Statement of changes in beneficial ownership of securities-Director Silverman Joshua

Apr 10 16:08 ET

Synaptogenix | 8-K: Current report

Apr 4 17:02 ET

Synaptogenix | 10-K: Annual report

Apr 1 17:04 ET

Synaptogenix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.

Feb 6 10:17 ET

Synaptogenix | 8-K: Current report

Dec 21, 2023 17:00 ET

Synaptogenix | ARS: Annual Report to Security Holders

Nov 14, 2023 17:05 ET

Synaptogenix: Q3 2023 Earnings Report

Nov 14, 2023 17:00 ET

Synaptogenix | DEF 14A: Definitive information statements

Nov 13, 2023 17:00 ET

Synaptogenix | 8-K: Current report

Nov 6, 2023 17:00 ET

Synaptogenix | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Nov 3, 2023 17:00 ET

Synaptogenix | 8-K: Current report

Sep 22, 2023 16:05 ET

Synaptogenix | 10-Q: Q2 2023 Earnings Report

Aug 14, 2023 17:00 ET

Synaptogenix | 8-K: Current report

Jul 19, 2023 08:55 ET

Synaptogenix | 8-K: Current report

Jun 22, 2023 17:14 ET

Synaptogenix | 10-Q: Q1 2023 Earnings Report

May 15, 2023 16:33 ET

Synaptogenix | 8-K: Current report

Apr 28, 2023 17:00 ET

Synaptogenix | 8-K: Current report

Apr 14, 2023 17:00 ET